{"id":397550,"date":"2020-12-10T10:53:10","date_gmt":"2020-12-10T15:53:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397550"},"modified":"2020-12-10T10:53:10","modified_gmt":"2020-12-10T15:53:10","slug":"thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/","title":{"rendered":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Dec. 10, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for NEOS, ONCT, HTBX, FCEL, and CIDM.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" title=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" alt=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>To see how InvestorsObserver&#8217;s proprietary scoring system rates these stocks, view the InvestorsObserver&#8217;s PriceWatch Alert by selecting the corresponding link.<\/p>\n<ul type=\"disc\">\n<li>NEOS: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3009332-2&amp;h=1359321372&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DNEOS%26prnumber%3D121020205&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DNEOS%26prnumber%3D121020205\" rel=\"nofollow noopener noreferrer\">https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=NEOS&amp;prnumber=121020205<\/a><\/li>\n<li>ONCT: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3009332-2&amp;h=2065777270&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DONCT%26prnumber%3D121020205&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DONCT%26prnumber%3D121020205\" rel=\"nofollow noopener noreferrer\">https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=ONCT&amp;prnumber=121020205<\/a><\/li>\n<li>HTBX: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3009332-2&amp;h=3522863012&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DHTBX%26prnumber%3D121020205&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DHTBX%26prnumber%3D121020205\" rel=\"nofollow noopener noreferrer\">https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=HTBX&amp;prnumber=121020205<\/a><\/li>\n<li>FCEL: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3009332-2&amp;h=4223941075&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DFCEL%26prnumber%3D121020205&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DFCEL%26prnumber%3D121020205\" rel=\"nofollow noopener noreferrer\">https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=FCEL&amp;prnumber=121020205<\/a><\/li>\n<li>CIDM: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3009332-2&amp;h=2050515889&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DCIDM%26prnumber%3D121020205&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fstocksymbol%3DCIDM%26prnumber%3D121020205\" rel=\"nofollow noopener noreferrer\">https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=CIDM&amp;prnumber=121020205<\/a><\/li>\n<\/ul>\n<p>(Note: You may have to copy this link into your browser then press the [ENTER] key.)<\/p>\n<p>InvestorsObserver&#8217;s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock&#8217;s overall suitability for investment.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG20286&amp;sd=2020-12-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp-301190583.html\">http:\/\/www.prnewswire.com\/news-releases\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp-301190583.html<\/a><\/p>\n<p>SOURCE  InvestorsObserver<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG20286&amp;Transmission_Id=202012101050PR_NEWS_USPR_____CG20286&amp;DateId=20201210\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for NEOS, ONCT, HTBX, FCEL, and CIDM. To see how InvestorsObserver&#8217;s proprietary scoring system rates these stocks, view the InvestorsObserver&#8217;s PriceWatch Alert by selecting the corresponding link. NEOS: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=NEOS&amp;prnumber=121020205 ONCT: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=ONCT&amp;prnumber=121020205 HTBX: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=HTBX&amp;prnumber=121020205 FCEL: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=FCEL&amp;prnumber=121020205 CIDM: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=CIDM&amp;prnumber=121020205 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver&#8217;s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock&#8217;s overall suitability for investment. \u00a0 View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp-301190583.html SOURCE InvestorsObserver<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397550","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for NEOS, ONCT, HTBX, FCEL, and CIDM. To see how InvestorsObserver&#8217;s proprietary scoring system rates these stocks, view the InvestorsObserver&#8217;s PriceWatch Alert by selecting the corresponding link. NEOS: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=NEOS&amp;prnumber=121020205 ONCT: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=ONCT&amp;prnumber=121020205 HTBX: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=HTBX&amp;prnumber=121020205 FCEL: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=FCEL&amp;prnumber=121020205 CIDM: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=CIDM&amp;prnumber=121020205 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver&#8217;s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock&#8217;s overall suitability for investment. \u00a0 View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp-301190583.html SOURCE InvestorsObserver\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T15:53:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?\",\"datePublished\":\"2020-12-10T15:53:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/\"},\"wordCount\":183,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/\",\"name\":\"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"datePublished\":\"2020-12-10T15:53:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/","og_locale":"en_US","og_type":"article","og_title":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk","og_description":"PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for NEOS, ONCT, HTBX, FCEL, and CIDM. To see how InvestorsObserver&#8217;s proprietary scoring system rates these stocks, view the InvestorsObserver&#8217;s PriceWatch Alert by selecting the corresponding link. NEOS: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=NEOS&amp;prnumber=121020205 ONCT: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=ONCT&amp;prnumber=121020205 HTBX: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=HTBX&amp;prnumber=121020205 FCEL: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=FCEL&amp;prnumber=121020205 CIDM: https:\/\/www.investorsobserver.com\/lp\/pr-stocks-lp-2\/?stocksymbol=CIDM&amp;prnumber=121020205 (Note: You may have to copy this link into your browser then press the [ENTER] key.) InvestorsObserver&#8217;s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock&#8217;s overall suitability for investment. \u00a0 View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp-301190583.html SOURCE InvestorsObserver","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T15:53:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?","datePublished":"2020-12-10T15:53:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/"},"wordCount":183,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/","name":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","datePublished":"2020-12-10T15:53:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-buying-stock-in-neos-therapeutics-oncternal-therapeutics-heat-biologics-fuelcell-energy-or-cinedigm-corp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Thinking about buying stock in Neos Therapeutics, Oncternal Therapeutics, Heat Biologics, FuelCell Energy, or Cinedigm Corp?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397550"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397550\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}